American Journal of Kidney Diseases

Renal Cortical Infarction Following Treatment With Sumatriptan in a Kidney Allograft Recipient

Published:December 03, 2012DOI:
      Renal cortical infarction is a rare cause of acute kidney injury that results from inadequate blood flow to the kidney, most commonly as a consequence of thrombotic or embolic occlusion of the renal artery or profound hypoperfusion. We report the case of a 78-year-old female kidney transplant recipient who developed a migraine headache, took sumatriptan, and soon after developed pain over the allograft and oligoanuric acute kidney injury. Kidney allograft biopsy showed renal cortical infarction. The mechanism of action of sumatriptan involves vasoconstriction, which counters the vasodilatation that is central to the pathogenesis of migraines. This case raises important questions regarding the safety of triptans with calcineurin inhibitors (which also act to vasoconstrict), particularly in elderly patients.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Tadipatri S.
        • Feniuk W.
        • Saxena P.R.
        Rabbit isolated renal artery contractions by some tryptamine derivatives, including 2-methyl-5-HT, are mediated by a 5-HT1-like receptor.
        Br J Pharmacol. 1992; 107: 322-328
        • Hinton J.M.
        • Hill P.
        • Jeremy J.
        • Garland C.
        Signalling pathways activated by 5-HT(1B)/5-HT(1D) receptors in native smooth muscle and primary cultures of rabbit renal artery smooth muscle cells.
        J Vasc Res. 2000; 37: 457-468
        • Loder E.
        Triptan therapy in migraine.
        N Engl J Med. 2010; 363: 63-70
        • Tepper S.J.
        • Stillman M.J.
        Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine.
        Headache. 2008; 48: 1259-1268
        • Hall G.C.
        • Brown M.M.
        • Mo J.
        • MacRae K.D.
        Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice.
        Neurology. 2004; 62: 563-568
        • Moawad F.J.
        • Goldkind L.
        An unusual case of colonic ischemia.
        South Med J. 2009; 102: 405-407
        • Barra S.
        • Lanero S.
        • Madrid A.
        • et al.
        Sumatriptan therapy for headache and acute myocardial infarction.
        Expert Opin Pharmacother. 2010; 11: 2727-2737
        • Madhrira M.M.
        • Mohan S.
        • Markowitz G.S.
        • Pogue V.A.
        • Cheng J.T.
        Acute bilateral renal infarction secondary to cocaine-induced vasospasm.
        Kidney Int. 2009; 76: 576-580
        • Domanovits H.
        • Paulis M.
        • Nikfardjam M.
        • et al.
        Acute renal infarction.
        Medicine (Baltimore). 1999; 78: 386-394
        • Janssen van Doorn K.
        • Van der Niepen P.
        • van Tussenbroeck F.
        • Verbeelen D.
        Acute tubulo-interstitial nephritis and renal infarction secondary to ergotamine therapy.
        Nephrol Dial Transplant. 2000; 15: 1877-1879
        • Huang C.C.
        • Lo H.C.
        • Huang H.H.
        • et al.
        ED presentations of acute renal infarction.
        Am J Emerg Med. 2007; 25: 164-169
        • Shanley P.F.
        • Rosen M.D.
        • Brezis M.
        • Silva P.
        • Epstein F.H.
        • Rosen S.
        Topography of focal proximal tubular necrosis after ischemia with reflow in the rat kidney.
        Am J Pathol. 1986; 122: 462-468
        • Kanchanabat B.
        • Siddins M.
        • Coates T.
        • et al.
        Segmental infarction with graft dysfunction: an emerging syndrome in renal transplantation?.
        Nephrol Dial Transplant. 2002; 17: 123-128
        • Cosio F.G.
        • Pesavento T.E.
        • Sedmak D.D.
        • et al.
        Clinical implications of the diagnosis of renal allograft infarction by percutaneous biopsy.
        Transplantation. 1998; 66: 467-471
        • Naesens M.
        • Kuypers D.R.
        • Sarwal M.
        Calcineurin inhibitor nephrotoxicity.
        Clin J Am Soc Nephrol. 2009; 4: 481-508
        • Bobadilla N.A.
        • Gamba G.
        New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone.
        Am J Physiol Renal Physiol. 2007; 293: F2-F9
        • Busauschina A.
        • Schnuelle P.
        • van der Woude F.J.
        Cyclosporine nephrotoxicity.
        Transplant Proc. 2004; 36: 229S-233S
        • Malacarne S.
        • Moll S.
        • Hadaya K.
        • Buhler L.
        • Martin P.Y.
        Renal ischaemic injuries during the use of zolmitriptan for treatment of migraines in a transplanted patient under tacrolimus therapy.
        Nephrol Dial Transplant. 2007; 22: 3341-3343
        • Fulton J.A.
        • Kahn J.
        • Nelson L.S.
        • Hoffman R.S.
        Renal infarction during the use of rizatriptan and zolmitriptan: two case reports.
        Clin Toxicol (Phila). 2006; 44: 177-180
        • Robbins M.S.
        • Lipton R.B.
        The epidemiology of primary headache disorders.
        Semin Neurol. 2010; 30: 107-119
        • Stokes M.
        • Becker W.J.
        • Lipton R.B.
        • et al.
        Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
        Headache. 2011; 51: 1058-1077